全球诊断剂市场规模、份额、趋势和成长分析报告（2026-2034）

预计诊断剂市场将从 2025 年的 655.5 亿美元成长到 2034 年的 1,202.1 亿美元，2026 年至 2034 年的复合年增长率为 6.97%。

受对精准早期疾病检测需求不断增长的推动，全球诊断剂市场持续稳定扩张。感染疾病、癌症和慢性病的日益流行，加速了医院和实验室对诊断试剂盒和试剂的使用。临床检测量的成长，尤其是在后疫情时代，进一步巩固了全球市场的发展趋势。

分子诊断、免疫检测和就地检验技术的进步是成长要素。人口老化和日益增强的健康意识也进一步促进了诊断检测率的提升。此外，新兴经济体政府为加强检查室基础设施建设和扩大筛检计画所做的努力，也为市场的永续发展做出了贡献。

展望未来，自动化、个人化医疗和人工智慧整合诊断平台的进步预计将对市场产生积极影响。试剂配方的持续创新和伴随诊断的日益普及将支撑市场的长期成长。居家检测和快速检测解决方案的推广预计将在未来几年开闢新的收入来源。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球诊断剂市场：依产品类型划分

• 市场分析、洞察与预测
• 层析法试剂
• 分子诊断剂
• 免疫检测试剂
• 临床化学试剂
• 流式细胞技术试剂
• 细胞和组织培养试剂
• 血液学和止血试剂
• 微生物试剂
• 其他的

第五章 全球诊断剂市场：依最终用户划分

• 市场分析、洞察与预测
• 医院和诊断检查室
• 学术研究机构
• 其他的

第六章 全球诊断剂市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 亚太其他地区
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第七章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第八章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Becton Dickinson And Company
  • Siemens Healthineers
  • Sysmex Corporation
  • DiaSorin SPA
  • BioMerieux SA
  • Ortho Clinical Diagnostics
  • Thermo Fisher Scientific Inc
  • Agilent Technologies Inc

The Diagnostic Reagents Market size is expected to reach USD 120.21 Billion in 2034 from USD 65.55 Billion (2025) growing at a CAGR of 6.97% during 2026-2034.

The Global Diagnostic Reagents Market is witnessing steady expansion due to the increasing demand for accurate and early disease detection. Rising prevalence of infectious diseases, cancer, and chronic disorders has accelerated the use of diagnostic kits and reagents across hospitals and laboratories. Growth in clinical testing volumes, especially post-pandemic, continues to strengthen market momentum worldwide.

Key drivers include advancements in molecular diagnostics, immunoassays, and point-of-care testing technologies. The growing elderly population and increasing healthcare awareness are further boosting diagnostic testing rates. Additionally, government initiatives to enhance laboratory infrastructure and expand screening programs in emerging economies are contributing to sustained market development.

Looking ahead, the market is expected to benefit from automation, personalized medicine, and AI-integrated diagnostic platforms. Continuous innovation in reagent formulations and the rising adoption of companion diagnostics will support long-term growth. Expansion of home-based and rapid testing solutions is likely to open new revenue streams in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Chromatography Reagents
• Molecular Diagnostic Reagents
• Immunoassay Reagents
• Clinical Chemistry Reagents
• Flow Cytometry Reagents
• Cell And Tissue Culture Reagents
• Hematology And Hemostasis Reagents
• Microbiology Reagents
• Others

By End-user

• Hospitals And Diagnostics Laboratories
• Academic And Research Institutes
• Others

COMPANIES PROFILED

• Abbott Laboratories, F HoffmannLa Roche AG, Becton Dickinson and Company, Siemens Healthineers, Sysmex Corporation, DiaSorin SpA, bioMerieux SA, Ortho Clinical Diagnostics, Thermo Fisher Scientific Inc, Agilent Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIAGNOSTIC REAGENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Chromatography Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Molecular Diagnostic Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Immunoassay Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Clinical Chemistry Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Flow Cytometry Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Cell And Tissue Culture Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Hematology And Hemostasis Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Microbiology Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIAGNOSTIC REAGENTS MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospitals And Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Academic And Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIAGNOSTIC REAGENTS MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Product Type
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Product Type
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Product Type
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Product Type
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Product Type
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL DIAGNOSTIC REAGENTS INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Abbott Laboratories
  • 8.2.2 F. Hoffmann-La Roche AG
  • 8.2.3 Becton Dickinson And Company
  • 8.2.4 Siemens Healthineers
  • 8.2.5 Sysmex Corporation
  • 8.2.6 DiaSorin S.P.A
  • 8.2.7 BioMerieux SA
  • 8.2.8 Ortho Clinical Diagnostics
  • 8.2.9 Thermo Fisher Scientific Inc
  • 8.2.10 Agilent Technologies Inc